Skip to content
Clinical Trials
Our Network
Our Story
Clinical Trials
Our Network
Our Story
OnCore Login
Clinical Trials
Current Trials
Publications
Our Network
Clinical Trial Working Groups
Sponsor-Investigators
Fostering an Environment of Mentorship
Member Sites
Partners in Research
About
Our Story
Our Team
Annual Reports
Services
Biorepository & Correlative Services
Rapid Accrual
Efficient Timelines for Activation
Regulatory Compliance
Accurate & Relevant Data
News & Events
HCRN Calendar
Oncology Meetings
Make a Difference
Donate Now
Fundraising Events
Advocacy Organizations
Honor Your Hero
Careers
Contact
OnCore Login
network member
Huntsman Cancer Institute at the University of Utah
1950 Circle of Hope Drive, Salt Lake City, UT 84112
About Network Member
Website
:
Huntsman Cancer Institute at the University of Utah
https://healthcare.utah.edu/huntsmancancerinstitute/
Enrollment Closed
HCRN-GU16-257
Neoadjuvant gemcitabine, cisplatin, plus nivolumab in patients with muscle-invasive bladder cancer with selective bladder sparing
Matthew D. Galsky
Cancer areas:
Bladder
City of Hope
Huntsman Cancer Institute at the University of Utah
Icahn School of Medicine at Mount Sinai
Knight Cancer Institute at Oregon Health & Science University
Penn Medicine Abramson Cancer Center
University of Wisconsin Carbone Cancer Center
USC Norris Comprehensive Cancer Center
Learn More
See clinicaltrials.gov
Enrollment Closed
HCRN-GU16-287
Randomized phase 2 trial of gemcitabine + carboplatin + nivolumab versus gemcitabine + oxaliplatin + nivolumab in cisplatin-ineligible patients with metastatic urothelial cancer
Matthew D. Galsky
Cancer areas:
Bladder
Urothelial Carcinoma
Huntsman Cancer Institute at the University of Utah
Icahn School of Medicine at Mount Sinai
Rutgers Cancer Institute of New Jersey
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vanderbilt-Ingram Cancer Center
Learn More
See clinicaltrials.gov
Current Trials
Our Network
Our Story
X